Small-area analysis of incidence and localisation of vulvar cancer
- PMID: 20652011
- PMCID: PMC2906180
- DOI: 10.1155/2010/512032
Small-area analysis of incidence and localisation of vulvar cancer
Abstract
Objective. Vulvar cancer is a rare disease mainly in older women. HPV and non-HPV induced vulvar cancer reflect two types of oncogenesis. Controversies exist on most recent developments in vulvar cancer incidence, patients, and disease characteristics. Changes in incidence, age of disease onset, and tumor site in women treated for primary vulvar cancer in a single German university hospital unit will be described. Methods. A retrospective analysis of patient records of women treated between 1994 and 2008 was performed. The fifteen-year-spanning period was divided into three five year-spanning cohorts. Descriptive and statistical analyses were performed. Results. 104 patients were identified: cohort-1 from 1994 to 1998 (11 patients); cohort-2 from 1999 to 2003 (21 patients); cohort-3 from 2004 to 2008 (72 patients). Mean age (years) was 73.18 (confidence interval (CI): 64.04; 82.33), 58.9 (CI: 52.24; 65.57), and 61.19 (CI: 57.27; 65.12), respectively. Vulvar cancer confined to the region between clitoris and urethra was seen more often in cohort-3 (n = 20) compared to cohort-1 (n = 0) or cohort-2 (n = 1). Conclusion. This analysis supports the notion of rising incidence of vulvar cancer and a changing pattern of anatomical local extension. Disease onset is not restricted to older women.
Figures


Similar articles
-
New aspects of vulvar cancer: changes in localization and age of onset.Gynecol Oncol. 2008 Jun;109(3):340-5. doi: 10.1016/j.ygyno.2008.01.041. Epub 2008 Apr 14. Gynecol Oncol. 2008. PMID: 18407339
-
Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma.Gynecol Oncol. 2020 May;157(2):450-455. doi: 10.1016/j.ygyno.2020.01.029. Epub 2020 Feb 7. Gynecol Oncol. 2020. PMID: 32037194
-
Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018.Cancer Prev Res (Phila). 2022 Nov 1;15(11):777-784. doi: 10.1158/1940-6207.CAPR-22-0086. Cancer Prev Res (Phila). 2022. PMID: 35969832
-
Vulvar intraepithelial neoplasia and vulvar cancer.Obstet Gynecol Clin North Am. 1996 Jun;23(2):295-324. Obstet Gynecol Clin North Am. 1996. PMID: 8784883 Review.
-
Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review.Curr Probl Cancer. 2018 Sep;42(5):476-485. doi: 10.1016/j.currproblcancer.2018.06.008. Epub 2018 Jul 5. Curr Probl Cancer. 2018. PMID: 30093165 Review.
Cited by
-
Gynecological Cancer Age Groups at the "Dr. Salvator Vuia" Clinical Obstetrics and Gynecology Hospital during the 2000-2009 Period.Maedica (Bucur). 2011 Oct;6(4):268-71. Maedica (Bucur). 2011. PMID: 22879839 Free PMC article.
-
Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis.PLoS One. 2015 May 28;10(5):e0128073. doi: 10.1371/journal.pone.0128073. eCollection 2015. PLoS One. 2015. PMID: 26020540 Free PMC article.
References
-
- Deutsche Krebsgesellschaft (DKG) Deutsche Gesellschaft für Gynäkologie und Geburtshilfe. Diagnostik und Therapie des Vulvakarzinoms und seiner Vorstufen, AWMF 032/032 (S2k) statements. 2008, http://www.dggg.de.
-
- Schnürch HG, Hantschmann P. Vulvar cancer: diagnosis and treatment. Der Gynäkologe. 2008;41(3):215–227.
-
- Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG. New aspects of vulvar cancer: changes in localization and age of onset. Gynecologic Oncology. 2008;109(3):340–345. - PubMed
-
- Akerman G, Dussour C, Haddad B, Paniel B-J, Rouzier R. Epidemiology of vulvar intra-epithelial neoplasias. Gynecologie Obstetrique Fertilite. 2007;35(12):1251–1256. - PubMed
-
- Cancer Research UK. UK vulva cancer incidence statistics. 2008, http://info.cancerresearchuk.org/cancerstats/types/vulva/incidence/.
LinkOut - more resources
Full Text Sources